Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer

This trial was designed to assess efficacy and safety of erlotinib with sorafenib in the treatment of patients with advanced pancreatic adenocarcinoma. An exploratory correlative study analyzing pretreatment serum samples using a multivariate protein mass spectrometry-based test (VeriStrat®), previo...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardin, Dana B, Goff, Laura, Li, Chung-I, Shyr, Yu, Winkler, Charles, DeVore, Russell, Schlabach, Larry, Holloway, Melanie, McClanahan, Pam, Meyer, Krista, Grigorieva, Julia, Berlin, Jordan, Chan, Emily
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101748/
https://www.ncbi.nlm.nih.gov/pubmed/24574334
http://dx.doi.org/10.1002/cam4.208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101748/
https://www.ncbi.nlm.nih.gov/pubmed/24574334
http://dx.doi.org/10.1002/cam4.208

Ejemplares similares